CRO/CMO concept fluctuates and rebounds, Haoyuan pharmaceuticals hits limit up.

The concept of CRO/CMO fluctuated and rebounded, Hao Yuan Medicine hit the daily limit, Zhao Yan New Drug, BioSci, Cayman Pharma, Yinuosi, Medici, and Pharm Kang Bio followed the rise.